Fundraising Fox
/Companies
Sign in

myNEO Therapeutics

Founded 2018 · 18 employees on LinkedIn · 1 known investors

Find your way into myNEO Therapeutics

Sign up to find every way you can get introduced to myNEO Therapeutics

  • Your email: who you already know at myNEO Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the myNEO Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs. The company serves pharmaceutical and biotech organizations across target discovery, optimization, and data analysis stages.

AI & Machine LearningBiotechHealthtechSaaS

Founders & leadership

Board

CBCedric Bogaert
Cedric BogaertEntrepreneur in Residence - managing myNEO at Novalis Biotech
JVJan Van Den Berghe
Jan Van Den BergheCo-Founder / Managing Director at Novalis Biotech
WVWim van Criekinge
Wim van CriekingeCo-Founder / Managing Director at Novalis Biotech

Investors · 1

Frequently asked questions

What does myNEO Therapeutics do?
myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs. The company serves pharmaceutical and biotech organizations across target discovery, optimization, and data analysis stages.
Who are myNEO Therapeutics's investors?
myNEO Therapeutics's investors include Novalis Biotech.